Abstract:

Drug-resistant pulmonary tuberculosis is characterized by complex treatment regimens, long treatment courses, high medical costs, low treatment compliance, and low cure rates. It is a difficult and key issue in tuberculosis control in China. In recent years, the clinical application of traditional Chinese medicine (TCM) in the treatment of drug-resistant pulmonary tuberculosis has become increasingly widespread, and the evidence-based evidence for the prevention and treatment of drug-resistant pulmonary tuberculosis through the combination of Chinese and Western medicine has been continuously accumulating. However, in clinical practice, there are often phenomena of non-standard and unreasonable application of TCM or combined TCM and Western medicine treatment plans. Currently, there is no industry guideline for the combined diagnosis and treatment plan of drug-resistant pulmonary tuberculosis with Chinese and Western medicine. Therefore, Chinese Association of Integrative Medicine, China Association of Chinese Medicine, and Chinese Medical Association have organized experts in related fields to formulate the “Diagnosis and treatment of the integrated Chinese and western medicine guidelines for drug-resistant pulmonary tuberculosis” based on the actual situation of the combined diagnosis and treatment of drug-resistant pulmonary tuberculosis with Chinese and Western medicine in China. This guideline is oriented towards clinical key issues, adheres to the basic principles of evidence-based medicine and the characteristics of evidence-based medicine in TCM, objectively evaluates the clinical evidence of the combined diagnosis and treatment of drug-resistant pulmonary tuberculosis with Chinese and Western medicine, and covers aspects such as the diagnosis, treatment, and prevention and regulation of drug-resistant tuberculosis with Chinese and Western medicine. The aim is to fully leverage the theoretical characteristics of TCM, highlight the synergistic and detoxifying advantages of the combined diagnosis and treatment of drug-resistant pulmonary tuberculosis with Chinese and Western medicine, further standardize the combined diagnosis and treatment process of drug-resistant pulmonary tuberculosis, and improve the diagnosis and treatment level of drug-resistant pulmonary tuberculosis in China.

Key words: Drug resistance, Tuberculosis, pulmonary, Medicine, Chinese traditional, Diagnosis, Treatment